Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GEBBIA, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.028
EU - Europa 4.110
AS - Asia 3.745
SA - Sud America 617
AF - Africa 91
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.608
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.865
SG - Singapore 1.325
RU - Federazione Russa 1.143
IT - Italia 879
CN - Cina 866
BR - Brasile 490
HK - Hong Kong 427
VN - Vietnam 362
DE - Germania 331
UA - Ucraina 321
FI - Finlandia 293
PL - Polonia 268
BD - Bangladesh 227
GB - Regno Unito 222
FR - Francia 191
IE - Irlanda 177
JP - Giappone 129
SE - Svezia 107
IN - India 86
CA - Canada 73
KR - Corea 70
AR - Argentina 46
MX - Messico 45
TR - Turchia 44
IQ - Iraq 38
NL - Olanda 37
AT - Austria 32
RO - Romania 24
ZA - Sudafrica 23
CO - Colombia 18
EC - Ecuador 18
UZ - Uzbekistan 18
BE - Belgio 17
ES - Italia 16
PK - Pakistan 16
ID - Indonesia 14
MY - Malesia 14
MA - Marocco 13
AE - Emirati Arabi Uniti 12
IR - Iran 11
PH - Filippine 11
VE - Venezuela 11
CL - Cile 10
JO - Giordania 10
PY - Paraguay 10
AU - Australia 9
JM - Giamaica 9
KE - Kenya 9
TN - Tunisia 9
EG - Egitto 8
GE - Georgia 8
GR - Grecia 8
SA - Arabia Saudita 8
CH - Svizzera 7
CI - Costa d'Avorio 7
HN - Honduras 7
DZ - Algeria 6
IL - Israele 6
LT - Lituania 6
UY - Uruguay 6
AL - Albania 5
BG - Bulgaria 5
ET - Etiopia 5
NP - Nepal 5
PS - Palestinian Territory 5
BF - Burkina Faso 4
BH - Bahrain 4
BO - Bolivia 4
CR - Costa Rica 4
KW - Kuwait 4
KZ - Kazakistan 4
NI - Nicaragua 4
OM - Oman 4
SV - El Salvador 4
AO - Angola 3
BB - Barbados 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EU - Europa 3
GT - Guatemala 3
LB - Libano 3
PE - Perù 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BY - Bielorussia 2
DM - Dominica 2
HU - Ungheria 2
LV - Lettonia 2
MN - Mongolia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
CG - Congo 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GD - Grenada 1
HR - Croazia 1
Totale 17.590
Salva come PNG Salva come JPEG
Città #
Fairfield 1.081
Ashburn 990
Singapore 896
Woodbridge 565
San Jose 521
Houston 503
Chandler 468
Seattle 422
Wilmington 415
Hong Kong 411
Cambridge 354
Ann Arbor 282
Moscow 243
Zgierz 224
Dublin 178
Jacksonville 172
Palermo 169
Beijing 156
Medford 155
Santa Clara 145
Council Bluffs 126
Des Moines 126
Tokyo 121
Ho Chi Minh City 120
Altamura 117
Los Angeles 117
Frankfurt am Main 99
Lauterbourg 97
Princeton 97
Dallas 94
Lawrence 88
Nanjing 87
New York 84
Hefei 82
Hanoi 78
Helsinki 77
San Diego 69
Boardman 63
Buffalo 57
São Paulo 53
Chicago 52
Dearborn 49
The Dalles 49
Tulsa 47
London 46
Milan 43
Columbus 35
Shenyang 35
Rome 32
Hebei 29
Warsaw 28
Ludwigshafen am Rhein 25
Phoenix 25
Da Nang 24
Orem 24
Changsha 23
Nanchang 23
Nuremberg 22
Rio de Janeiro 22
Saint Petersburg 21
Atlanta 20
Tianjin 20
Denver 19
Guangzhou 18
Jinan 18
Brussels 17
Redwood City 17
Amsterdam 16
Baghdad 16
Brooklyn 16
San Paolo di Civitate 16
Seongnam 16
Toronto 16
Jiaxing 15
Johannesburg 15
Mumbai 15
San Francisco 15
San Mateo 15
Zhengzhou 15
Brasília 14
Izmir 14
Kumar 14
Paris 14
Seoul 14
Stockholm 14
Falls Church 13
Montreal 13
Tashkent 13
Vienna 13
Berlin 12
City of London 12
Manchester 12
Ningbo 12
Belo Horizonte 11
Boston 11
Chennai 11
Florence 11
Polska 11
Ankara 10
Haiphong 10
Totale 11.430
Salva come PNG Salva come JPEG
Nome #
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: A prospective study 366
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 287
Does pain intensity predict a poor opioid response in cancer patients? 278
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor 274
Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit. 270
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy 263
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy 260
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale 258
Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents 243
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial. 240
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 224
WHATSAPP MESSENGER AS A REAL-TIME TOOL FOR A LONG-DISTANCE ACTIVITY OF A MULTIDISCIPLINARY 219
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia. 217
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 216
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 207
ELF regimen in advanced gastrointestinal malignancies: An analysis of its clinical effectiveness and toxicity 205
Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience 204
Breakthrough pain in oncology: a longitudinal study. 203
A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma 203
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). 199
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule 199
Anticancer oral therapy: Emerging related issues 198
Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study. 197
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases 196
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials 195
Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. 192
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106). 191
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study 188
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5- Fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas 188
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials. 187
Combination chemotherapy of 5-Fluorouracil, Epidoxorubicin and Mitomicin C in the palliative treatment of locally-advanced and/or metastatic adenocarcinoma of the stomach. 186
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. 185
Oral versus intravenous vinorelbine: clinical safety profile 185
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study 184
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial 182
Oral vinorelbine may not induce acute pain at the tumor site. 181
Gastric metastasis from breast cancer 177
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 177
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 176
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study. 174
Treatment of advanced non-small cell lung cancer: chemotherapy with or without cisplatin? 174
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: A whatsapp messenger-based report from the Italian college of chief medical oncologists 174
A phase i-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma 173
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 171
Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer 170
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 170
Treatment of metastatic breast cancer with vinorelbine and docetaxel 169
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM) 168
Cetuximab in squamous cell head and neck carcinomas. 168
Latissimus Dorsi Flap and Thoracodorsal Artery Perforator Flap with Immediate Fat Transfer (LIFT and TIFT): A Retrospective Study about Total Breast Reconstruction in High-Risk Patients 167
Liability of clinical oncologists and the COVID-19 emergency: Between hopes and concerns 166
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 Study 165
Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials 164
Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.) 161
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer 160
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. 159
Italian clinical research in non-small-cell lung cancer 159
Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma 156
Ondasetron versus granisetron in the prevention of chemotherapy‐induced nausea and vomiting. Results of a prospective randomized trial 152
“Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium” 151
Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel 148
Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas 147
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial 146
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 146
Virtual clinical and precision medicine tumor boards-cloud-based platform-mediated implementation of multidisciplinary reviews among oncology centers in the covid-19 era: Protocol for an observational study 146
Cetuximab: clinical results in colorectal cancer. 145
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 145
Subcutaneous recombinant human erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer. 144
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma 143
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale 141
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience 140
MISURARE LA FRAGILITÀ DEL PAZIENTE ONCOLOGICO ANZIANO 138
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 138
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer 137
Opioid plasma concentration during switching from morphine to methadone: Preliminary data 134
Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management. 132
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 130
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. 129
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 129
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World 129
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 128
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 127
UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 124
Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with gluthatione protection in patients with advanced head and neck cancer 122
Safety and efficacy of the treatment with Nab-paclitaxel in mEtastatic bREast cancer In elDerly patiEnts: NEREIDE study 122
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma 121
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer 120
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety 112
Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM) 110
GEMCITABINE AND CISPLATIN FOR INOPERABLE AND/OR METASTATIC BILIARY TREE CARCINOMAS: A MULTICENTER PHASE II STUDY OF THE GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE (GOIM) 110
Mitoxantrone + Prednisone versus Taxotere + Prednisone nel trattamento del carcinoma prostatico ormonorefrattario (cpor ). Studio randomizzato di fase II del Gruppo Oncologico dell’Italia Meridionale (GOIM ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 109
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care 107
Short term intensive preoperative chemotherapy with high doses of epirubicin plus G-CSF rescue for locally advanced Stage III breast carcinoma. 106
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 106
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 105
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 104
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes 103
Cancer: New needs, new models. is it time for a community oncologist? another brick in the wall 101
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 100
Vinorelbine plus cisplatinum for the treatment of Stage IIIB and IV Non Small Cell Lung Carcinoma. 98
Totale 16.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.489
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.196 79 260 13 62 58 42 69 57 145 149 62 200
2022/20231.411 134 321 27 126 162 232 91 80 136 12 46 44
2023/2024602 29 97 67 48 37 92 46 27 12 15 40 92
2024/20251.874 50 166 183 144 96 60 130 109 124 194 202 416
2025/20266.767 428 231 401 445 687 931 882 686 545 778 344 409
2026/2027245 245 0 0 0 0 0 0 0 0 0 0 0
Totale 18.144